CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-24 | Patel Ronil A. SVP, Operations & Bus. Dev. | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-04-19 | MANUSO JAMES S J Director | Grant or award | +2,819 | 57,828 | ||
| 2023-04-19 | Benton Susan Director | Grant or award | +1,053 | 68,486 | ||
| 2023-04-19 | Rodgers Richard J Interim CEO and President | Grant or award | +50,000 | 138,246 | ||
| 2023-04-19 | Pepose Jay Director | Grant or award | +468 | 46,375 | ||
| 2023-01-11 | MANUSO JAMES S J Director | Grant or award | +18,544 | 55,009 | ||
| 2023-01-11 | Pepose Jay Director | Grant or award | +13,013 | 45,907 | ||
| 2023-01-11 | Rodgers Richard J Director | Grant or award | +20,822 | 88,246 | ||
| 2023-01-11 | Benton Susan Director | Grant or award | +16,267 | 67,433 | ||
| 2023-01-10 | Sooch Mina President and CEO | Grant or award | +134,456 | 430,501 | ||
| 2023-01-10 | Sooch Mina President and CEO | Grant or award · Employee Stock Option (right to buy) | +201,683 | 201,683 | ||
| 2023-01-10 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +33,291 | 33,291 | ||
| 2023-01-10 | Hoffmann Bernhard SVP of Corp. Dev. & Ops & Sec. | Grant or award | +46,608 | 146,728 | ||
| 2023-01-10 | Hoffmann Bernhard SVP of Corp. Dev. & Ops & Sec. | Grant or award · Employee Stock Option (right to buy) | +69,912 | 69,912 | ||
| 2023-01-10 | Zaremba Rabourn Amy SVP of Finance | Grant or award | +46,608 | 46,608 | ||
| 2023-01-10 | Zaremba Rabourn Amy SVP of Finance | Grant or award · Employee Stock Option (right to buy) | +69,912 | 69,912 | ||
| 2023-01-04 | Gallagher Cam Director | Option exercise | +1,574 | $0.00 | $0 | 24,928 |
| 2023-01-04 | Gallagher Cam Director | Option exercise · Series B Warrant (right to buy) | −1,574 | 0 | ||
| 2022-10-19 | Ainsworth Sean Director | Option exercise | +1,574 | $0.00 | $0 | 41,239 |
| 2022-10-19 | Ainsworth Sean Director | Option exercise · Series B Warrant (right to buy) | −1,574 | 0 |
Page 9 of 15 · 283 trades